Literature DB >> 18984157

The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells.

Yu-Fen Chou1, Hsu-Hsin Chen, Maureen Eijpe, Akiko Yabuuchi, Joshua G Chenoweth, Paul Tesar, Jun Lu, Ronald D G McKay, Niels Geijsen.   

Abstract

Pluripotent stem cell lines can be derived from blastocyst embryos, which yield embryonic stem cell lines (ES cells), as well as the postimplantation epiblast, which gives rise to epiblast stem cell lines (EpiSCs). Remarkably, ES cells and EpiSCs display profound differences in the combination of growth factors that maintain their pluripotent state. Molecular and functional differences between these two stem cell types demonstrate that the tissue of origin and/or the growth factor milieu may be important determinants of the stem cell identity. We explored how developmental stage of the tissue of origin and culture growth factor conditions affect the stem cell pluripotent state. Our findings indicate that novel stem cell lines, with unique functional and molecular properties, can be generated from murine blastocyst embryos. We demonstrate that the culture growth factor environment and cell-cell interaction play a critical role in defining several unique and stable stem cell ground states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984157      PMCID: PMC2767270          DOI: 10.1016/j.cell.2008.08.035

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.

Authors:  T C Doetschman; H Eistetter; M Katz; W Schmidt; R Kemler
Journal:  J Embryol Exp Morphol       Date:  1985-06

2.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

3.  A role for cadherins in tissue formation.

Authors:  L Larue; C Antos; S Butz; O Huber; V Delmas; M Dominis; R Kemler
Journal:  Development       Date:  1996-10       Impact factor: 6.868

4.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

Authors:  G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture.

Authors:  Y Matsui; K Zsebo; B L Hogan
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

6.  Long-term proliferation of mouse primordial germ cells in culture.

Authors:  J L Resnick; L S Bixler; L Cheng; P J Donovan
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

7.  E-cadherin null mutant embryos fail to form a trophectoderm epithelium.

Authors:  L Larue; M Ohsugi; J Hirchenhain; R Kemler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

8.  A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development.

Authors:  D Riethmacher; V Brinkmann; C Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

9.  Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.

Authors:  G R Martin; M J Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Dual adhesion systems of chick myoblasts.

Authors:  D Gibralter; D C Turner
Journal:  Dev Biol       Date:  1985-12       Impact factor: 3.582

View more
  99 in total

Review 1.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 2.  Regenerative chemical biology: current challenges and future potential.

Authors:  Ada Ao; Jijun Hao; Charles C Hong
Journal:  Chem Biol       Date:  2011-04-22

3.  Stemness as a cell default state.

Authors:  Jordi Casanova
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

4.  Direct reprogramming of fibroblasts into epiblast stem cells.

Authors:  Dong Wook Han; Boris Greber; Guangming Wu; Natalia Tapia; Marcos J Araúzo-Bravo; Kinarm Ko; Christof Bernemann; Martin Stehling; Hans R Schöler
Journal:  Nat Cell Biol       Date:  2010-12-05       Impact factor: 28.824

5.  Influence of E-cadherin-mediated cell adhesion on mouse embryonic stem cells derivation from isolated blastomeres.

Authors:  Sheyla González; Elena Ibáñez; Josep Santaló
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 6.  Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.

Authors:  Jacob H Hanna; Krishanu Saha; Rudolf Jaenisch
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

7.  Pluripotency takes off without Blimp1.

Authors:  Amander T Clark
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

8.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

9.  Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts.

Authors:  Deanne J Whitworth; Dmitry A Ovchinnikov; Jane Sun; Patrick R J Fortuna; Ernst J Wolvetang
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

10.  The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.

Authors:  Anthony D Krentz; Mark W Murphy; Shinseog Kim; Matthew S Cook; Blanche Capel; Rui Zhu; Angabin Matin; Aaron L Sarver; Keith L Parker; Michael D Griswold; Leendert H J Looijenga; Vivian J Bardwell; David Zarkower
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.